Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 30Triple Negative Breast Neoplasms 4Recurrence 2Unilateral Breast Neoplasms 1Pain 1Neoplasms 1Lymphedema 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Cancer Invasive 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 153Dexamethasone 140Rituximab 83fludarabine 79Cytarabine 69Lenalidomide 68Bortezomib 64fludarabine phosphate 62Gemcitabine 62venetoclax 55Etoposide 53pembrolizumab 52pomalidomide 49Paclitaxel 48Cisplatin 47Carboplatin 47Peripheral Blood Stem Cell Transplantation 46Filgrastim 40Radiotherapy 39Calcium Dobesilate 36Busulfan 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 29Vincristine 28Temozolomide 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Recurrence × Mastectomy × Clear all
NCT06704659 2026-03-09

RAY-no-BAN

Turku University Hospital

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Recurrence

NCT02464774 2015-06-08

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Sun Yat-sen University

Phase NA Unknown
464 enrolled
Breast

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡